2021 marked the 10 year anniversary since IMP was established. In that time, IMP has brought together 16 national patient organisations from around the world, and facilitated international discussions about mitochondrial diseases (mito). It has supported thousands of patients and their families, and has built a global mito community.
Relationships with other stakeholders, including clinicians, researchers, scientists and industry, continue to strengthen.
Who is IMP?
International Mito Patients is a network of national patient organisations involved in mito. The national patient organisations support and advocate for patients, fund research, increase awareness and improve education in their country.
By joining forces, IMP represents a large group of patients, creating a stronger voice on an international level.
IMP is a member of the European Organisation for Rare Diseases (EURODIS), which has international partners such as the National Organisation for Rare Diseases (NORD) and Canadian Organization for Rare Diseases (CORD).
